MedTrace Logo

Hospital-acquired Pneumonia in Intensive Care Unit

NCT03348579 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1850

Last updated 2020-05-12

No results posted yet for this study

Summary

hospital-acquired pneumonia are a common disease in intensive care unit. The prevention, the diagnosis and the treatment of hospital acquired pneumonia are a frequent challenge. Nevertheless it seems that there are great differences in standard of care between hospitals. The investigators hypothesized that medical education and implementation of evidence-base guidelines can reduce the duration of mechanical ventilation in patients presenting of hospital acquired pneumonia

Conditions

  • Hospital Acquired Pneumonia
  • Ventilator-Associated Pneumonia
  • Sepsis
  • Pneumonia

Interventions

OTHER

Guidelines publication and application

Passing recommendations on using the guidelines in the intensive care units

OTHER

Targeted experience feedback

Targeted experience feedback": On top of the standard training, the centers receive an analysis of the evolution of the practices of their center and the future of their patients between phases 1 and 2, as well as these same values for the data set. The centers are then called to conduct a meeting to determine their priority improvement points based on this audi

Sponsors & Collaborators

  • Société Française d'Anesthésie et de Réanimation

    collaborator OTHER

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Antoine Roquilly, PH · Nantes University Hospital

  • Marc Leone · AP-HM

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-15
Primary Completion
2018-10-15
Completion
2018-12-15

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03348579 on ClinicalTrials.gov